AU Stock MarketDetailed Quotes
NOX Noxopharm Ltd
- 0.110
- +0.014+14.58%
20min DelayMarket Closed Aug 23 15:45 AET
32.15MMarket Cap-2115P/E (Static)
0.115High0.092Low518.16KVolume0.092Open0.096Pre Close53.31KTurnover0.16552wk High0.27%Turnover Ratio292.24MShares0.03352wk Low-0.041EPS TTM20.99MFloat Cap1.590Historical HighLossP/E (Static)190.86MShs Float0.033Historical Low-0.052EPS LYR23.96%Amplitude--Dividend TTM4.78P/B1Lot Size--Div YieldTTM
About Noxopharm Ltd Company
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.
Company Profile
SymbolNOX
Company NameNoxopharm Ltd
Founded2015
MarketASX
Fiscal Year Ends06-30
Address60 Linksley Ave
CityGlenhaven
CountryAustralia
Zip Code2156
Websitehttps://www.noxopharm.com
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
Company Executives
- Name
- Position
- Salary
- Gisela Mautner
- Chief Executive Officer,Managing Director
- --
- Peter Ashley Marks
- Non-Executive Director,Non-Executive Deputy Chairman
- --
- Frederick (Fred) Bart
- Non-Executive Director,Non-Executive Chairman
- --
- Boris Patkin
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg